Autologous Bone Marrow-derived DCs(Soon Chun Hyang University Hospital)

N/A

Report date: 2024/11/07 10:58:04

Base Information

Drug NameAutologous Bone Marrow-derived DCs(Soon Chun Hyang University Hospital)

Drug Alias NameDentritic cell therapy(Soon Chun Hyang University Hospital)CellgramDC-WT1

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSoon Chun Hyang University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesSoon Chun Hyang University Hospital

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A